Science
Muscle-Invasive Bladder Cancer: Evolving Therapies and Access Gaps
In this article, we summarise a paper by Yüksel Ürün et al., published in the OncoDaily Medical Journal, on evolving therapies for MIBC and real-world access gaps in Turkey. Title: Muscle-Invasive Bladder Cancer: Evolving Therapies and Real-World Access Gaps in…
Gastrointestinal Oncology in Mexico: Incidence, Access, and the Path to Equity
In this article, we summarise a paper by Alejandro Noguez-Ramos et al., published in the OncoDaily Medical Journal, outlining Mexico’s GI-oncology landscape, epidemiology, health-system structure, treatment availability, training, and near-term opportunities. Title: Gastrointestinal oncology in MexicoAuthors: Alejandro Noguez-Ramos et al.DOI:…
GI Cancer in Guatemala: Risks, Care Gaps, and Priorities
In this article, we summarise a paper by Rixci Augusto Ramírez Fallas et al., published in the OncoDaily Medical Journal, offering a system-level view of gastrointestinal (GI) cancers in Guatemala, epidemiology, risk factors, care capacity, and priorities for prevention and…
Metastatic Melanoma: Five Decades of Treatment Progress
In this article, we summarise a paper by Agop Y. Bedikian, published in the OncoDaily Medical Journal, tracing how care for metastatic cutaneous melanoma moved from cytotoxic agents to precision targets and immune checkpoint blockade, and what still limits durable…
From Engineering to Oncology: A Life Shaped by Patients, Science, and Service
In this article, we summarise a paper by Agop Y. Bedikian, published in the OncoDaily Medical Journal, tracing the personal journey of an Armenian-Lebanese engineering student who became a cancer specialist, and how patient-centered care and clinical trials defined his…
Hematologic Oncology in Armenia: Progress, Bottlenecks, and What’s Next
In this article, we summarise a paper by Alisa Movsisyan et al., published in the OncoDaily Medical Journal, offering the first nationwide overview of hematologic oncology in Armenia, covering epidemiology, diagnostics, treatment, outcomes, and system gaps that shape care across…
From Imatinib to CAR-T: 20 Years of Leukaemia Progress
Advances in leukaemia treatment have accelerated from first-generation chemotherapy to precision targets and cellular immunotherapy. In this article, we summarise a paper by Robert Peter Gale, published in the OncoDaily Medical Journal, tracing that evolution across ALL, AML, CLL, and…